Many researchers are working to find ways to make bispecific antibody treatment easier for patients by reducing side effects like infections, low blood counts, neurological issues, and cytokine release syndrome.

In this section we will discuss: 

• What is being done to prevent side effects (including serious infections and neurological toxicities)?
• What is IVIG, and what role does it play in multiple myeloma treatment (including bispecific antibody therapy)?
• The impact of bispecific antibody treatment on patients' quality of life
   

Visit our Side Effects Solutions site in HealthTree Cure Hub to discover the experiences of other patients undergoing myeloma treatment and learn how they navigated these side effects to feel better.